GlobeNewswire

iCAD Announces Exceptional Study Results Demonstrating Significant Advantages of Revolutionary Artificial Intelligence Technology for Digital Breast Tomosynthesis

Del

Results demonstrate unprecedented improvements in clinical performance and reading times, validating the substantial benefits of artificial intelligence when used with 3D mammography

Company to showcase latest innovations in cancer detection at The European Society of Breast Imaging annual meeting in booth 14

NASHUA, N.H. and ATHENS, Greece, Oct. 11, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced outstanding clinical results of its new, leading-edge digital breast tomosynthesis (DBT) cancer detection software. The study demonstrated significant positive results for clinical performance and workflow efficiency.

The findings confirmed that the latest artificial intelligence (AI) software solution to support DBT increased improvements in both reader sensitivity (8.0 percent on average) and specificity (6.9 percent on average). In addition, when reading tomosynthesis cases with the solution, radiologists’ reading times were reduced by more than half (52.7 percent on average). 

“As incidence rates of breast cancer continue to rise, we are proud to provide valuable technology that is proven to significantly improve detection rates while reducing unnecessary recalls resulting from false positives. We also understand that radiologists are concerned about the extra workload and long reading times of tomosynthesis cases in everyday practice and we are pleased to have created a meaningful solution to address this problem,” said Jeff Hoffmeister, MD, Vice President and Medical Director at iCAD. “As tomosynthesis moves into the screening arena, our AI software provides important benefits to radiologists, their practices, and their patients.”

“iCAD’s unique technology assists me in detecting more cancers, reassures me of my findings, and helps me concentrate on the essential work of a radiologist. The product reduced my reading time by approximately 50 percent, allowing me to read these cases in nearly the same amount of time as 2D mammograms. I consider it to be one of the greatest tools in modern radiology,” said Dr. Axel Gräwingholt, Radiologie am Theater, Paderborn, Germany.

iCAD’s high-performance, concurrent read, cancer detection and workflow solution for breast tomosynthesis delivers critical benefits to both radiologists and their patients. The new technology is trained to detect malignancies and determine the probability of malignant findings, providing radiologists with a “certainty of finding” score for each case and each detected lesion. These scores represent the algorithm’s confidence that the detected soft tissue densities (masses, architectural distortions and asymmetries) and calcifications are malignant.

“Upon receiving CE mark approval and showcasing our solution at the European Congress of Radiology earlier this year, we’ve seen tremendous interest in our product among European radiologists,” said Ken Ferry, CEO of iCAD. “We are proud to be able to offer providers and patients alike greater access to an advanced breast cancer detection solution that is proven to substantially increase cancer detection performance and help to dramatically streamline workflows.”

iCAD’s revolutionary AI technology is available for use with leading digital breast tomosynthesis systems in Europe. The solution is pending clearance by the United States Food and Drug Administration (FDA). The company will showcase its latest innovations in cancer detection at The European Society of Breast Imaging annual meeting in booth 14 from October 11-13 at the Megaron Athens International Conference Center, Megaro Mousikis Athinon in Athens, Greece.

About iCAD, Inc.

Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

Certain statements contained in this News Release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to the Company’s ability to defend itself in litigation matters, to achieve business and strategic objectives, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, uncertainty of future sales levels, protection of patents and other proprietary rights, product market acceptance, possible technological obsolescence of products, increased competition, litigation and/or government regulation, changes in Medicare or other reimbursement policies, risks relating to our existing and future debt obligations, competitive factors, the effects of a decline in the economy or markets served by the Company; and other risks detailed in the Company’s filings with the Securities and Exchange Commission. The words “believe”, “demonstrate”, “intend”, “expect”, “would”, “could”, “consider”, “project”, “estimate”, “will”, “continue”, “anticipate”, “likely”, “seek”, and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. For additional disclosure regarding these and other risks faced by iCAD, please see the disclosure contained in our public filings with the Securities and Exchange Commission, including the 10-K for the year ended December 31, 2017, available on the Investors section of our website at http://www.icadmed.com and on the SEC’s website at http://www.sec.gov.

Contact:

Media Inquiries:

ARPR, on behalf of iCAD, Inc.
Paul Barren, +1 (855) 300-8209
paul@arpr.com

Investor Relations:
LifeSci Advisors
Jeremy Feffer, +1 (212) 915-2568
jeremy@lifesciadvisors.com

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Nordic Innovators Cloudstreet and Domos Partner to Deliver an End-to-End, Application-Aware 5G Experience to the Home22.2.2019 09:00:00Pressemelding

Cloudstreet’s carrier-grade API and Network Slicing platform with Domos’ Machine Learning Solution for home networks delivers intelligent connectivity out of the box Barcelona, Spain., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Finland’s Cloudstreet, the US-patented Network Slicing Company, and Norway’s Domos, a leader in Machine Learning technologies for the smart home, are pleased to announce that they have teamed up to create the industry’s first end-to-end, intelligent application and context-aware network slicing solution for home networks. The solution will be on display February 25-28 at the Mobile World Congress in Barcelona in Hall 5, stand 5C41. A perfect example of MWC’s aspirational theme, “Intelligent Connectivity”, the solution closes the loop on delivering a 5G experience to fixed wireless home networks. The combined technologies solve two key, last-mile problems that have plagued mobile-enabled home networks: 1) How to build application-awareness into the network without comprom

General Electric Company: Doc re. GE Files Form 8-K22.2.2019 08:00:00Pressemelding

FAIRFIELD, Conn., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Company General Electric Company ISIN US3696041033 Symbol London: GEC | Paris: GNE Headline Doc re: GE files Form 8-K February 21, 2019 On February 21, 2019, General Electric Company (the "Company") filed a Form 8-K with the U.S. Securities and Exchange Commission ("SEC"), which has been submitted to RNS. It is also available on the SEC's website at http://www.sec.gov and on the Company's website at https://www.ge.com/investor-relations/events-reports. http://www.rns-pdf.londonstockexchange.com/rns/8048Q_1-2019-2-21.pdf CONTACT: GE Jennifer Erickson +001 646 682 5620 jennifer.erickson@ge.com This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit

Northland Power Reports Full Year and Fourth Quarter 2018 Results22.2.2019 02:52:00Pressemelding

Results Reflect Successful Growth Strategy with Free Cash Flow per Share Up 30% and Adjusted EBITDA Up 17% TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today reported financial results for the three months and year ended December 31, 2018. “2018 was a significant year for Northland. We continued to operate safely and efficiently, achieving strong growth in free cash flow and adjusted EBITDA,” said Mike Crawley, President and Chief Executive Officer of Northland. “Construction of Deutsche Bucht project remains on time and on budget, and we also remain well-positioned for continued growth. Our expansion into Asia has gained further traction, with the first of the three Hai Long offshore wind projects securing all approvals and permits. The next step for this 300 MW project will be executing its PPA.” Highlights: 2018 Financial Results Sales increased 13% from $1.4 billion in 2017 to $1.6 billion and gross profit increased 17% t

NexusTours appoints Sham Ganiwalla as Business Development Director for Europe and Middle East21.2.2019 18:25:00Pressemelding

CANCUN, Mexico, Feb. 21, 2019 (GLOBE NEWSWIRE) -- NexusTours is pleased to announce that Sham Ganiwalla has joined the company as Business Development Director for the Europe and Middle Eastern markets. With a career spanning many years in tourism working for companies such as Tourico Holidays and Hotelbeds, Sham has extensive knowledge about different areas of the business, from product and marketing, to performance management and customer service. Reporting to Nadia Younes, Commercial Director Europe & MEAPAC, Sham will bring value to the development of Nexus' projects across the region. Rubén Gutiérrez, President Destination Services of Sunwing, commented, “The addition of Sham, will allow us to accelerate our commercial expansion in Europe and MEAPAC. We know that there are many travel partners that will value our expansion and positioning as regional leaders in destinations across America, our quality of service as “local experts”, as well as the ease of obtaining reservations thr

Segment Launches New Program to Help Early-Stage Startups Achieve Product-Market Fit and Maximize Growth21.2.2019 17:00:00Pressemelding

Startups Will Receive Up to Two Years’ Free Access to Segment’s CDI, Alongside Great Deals for Leading Applications from Google Cloud for Startups, Amplitude, Intercom, Mode Analytics and More SAN FRANCISCO`, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Segment, the customer data infrastructure company, today launched the Segment Startup Program, a new initiative that will provide early-stage companies with the financial, educational and business support they need to reach key product milestones and effectively grow their business. “Having seen thousands of small startups grow into large companies using Segment, we know that even the fastest-growing companies struggle with things such as finding product-market fit, ensuring future revenue streams, and optimizing the sales funnel,” said Ilya Volodarsky, co-founder of Segment. “This is something we certainly experienced ourselves when founding Segment back in 2011, when we were just four friends in a dorm room. Now that we have thousands of custome

PubMatic Launches OpenBid, Bringing Full Strength of Programmatic Monetization to the Mobile App Environment21.2.2019 15:00:00Pressemelding

The Programmatic-First SDK Offers App Developers Benefits of Header Bidding REDWOOD CITY, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- PubMatic, the publisher-focused sell-side platform (SSP) for an open digital media future, today announced the launch of OpenBid, a breakthrough programmatic-first solution that provides app publishers and developers with a gateway to programmatic demand and brand ad budgets. Consumers globally are increasingly interacting with media via mobile devices, and many brand advertisers are turning to in-app advertising to reach this highly-engaged audience. Many are focusing their budgets on automated buying channels such as the open exchange and private marketplaces, with over 90 percent of global media buyers planning to increase their programmatic direct in-app budgets in 2019 (Forrester Consulting). However, many app developers have been unable to fully capitalize on the growing interest from brand advertisers as they rely on legacy mobile mediation partners